Phospholipid and Liposome
for Pharmaceutical
Liposome formulation
Optimization & manufacturing of customer’s liposome encapsulated hydrophilic,hydrophobic,cationic drug
Based on our ample experience accumulated in the phospholipid/liposome fields, we are ready to comply with toll manufacture and toll development of drugencapsulated liposomes. We can offer proposals for development of various functional liposomes, such as those with improved half-life of the drug in the blood and those with immunoregulatory functions.
Based on our ample experience accumulated in the phospholipid/liposome fields, we are ready to comply with toll manufacture and toll development of drugencapsulated liposomes. We can offer proposals for development of various functional liposomes, such as those with improved half-life of the drug in the blood and those with immunoregulatory functions.
NOF has developed immunoregulatory liposomes and technology. This technology essentially requires production of an appropriate amount of IgG antibody, while concomitantly inhibiting the production of IgE antibody. Due to the wellknown advantages of strong cellular immunity (CTL activity), this technology can be applied to preparation of vaccines for infections and cancer, as well as for treatment of allergies, including pollen allergy.
Anti-OVA antibody production in mice with immunized Aluminum and Liposomal adjuvants.
8 weeks old femate BALBC mice were immunized intraperitoneally. After immunization,blood sample were taken from the tail vein.
Anti-OVA antibodies in the sera were determined.
8 weeks old femate BALBC mice were immunized intraperitoneally. After immunization,blood sample were taken from the tail vein.
Anti-OVA antibodies in the sera were determined.
   
|
|